WELLINGTON MANAGEMENT GROUP LLP

Position in BNTX — BioNTech SE

CIK 902219 Boston, MA

Position in BNTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$12,127,577

+$127,179 QoQ

Shares Held

130,334

-3.5% QoQ

Ownership

0.052%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#59

of 282 holders

Holding Since

Jun 2020

9 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $14,994,233,945 across 206 Biotechnology names. BNTX ranks #69 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,247,658	$1,613,209,155
2	ARGX	Argenx SE	930,548	$863,334,513
3	REGN	Regeneron Pharmaceuticals, Inc.	1,270,087	$791,950,042
4	RVMD	Revolution Medicines, Inc.	3,843,415	$719,794,757
5	ALNY	Alnylam Pharmaceuticals, Inc.	2,110,407	$635,295,816
6	IONS	Ionis Pharmaceuticals Inc	7,651,415	$606,680,693
7	CYTK	Cytokinetics Inc	6,931,770	$590,517,483
8	MDGL	Madrigal Pharmaceuticals, Inc.	825,714	$443,367,129

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$12,127,577	130,334	-3.5%	Shares	Defined	2026-08-14
2026-03-31	$12,000,398	135,018	+933.3%	Shares	Defined	2026-05-15
2025-12-31	$1,243,978	13,067	-92.6%	Shares	Defined	2026-02-17
2022-03-31	$30,106,396	176,515	-0.0%	Shares	Defined	2022-05-16
2021-12-31	$45,513,558	176,546	-51.8%	Shares	Defined	2022-02-11
2021-03-31	$39,966,813	366,030	-8.4%	Shares	Defined	2021-05-17
2020-12-31	$32,558,433	399,392	-30.5%	Shares	Defined	2021-02-12
2020-09-30	$39,759,063	574,304	-3.8%	Shares	Defined	2020-11-16
2020-06-30	$39,857,926	597,212	—	Shares	Defined	2020-08-14
No filing history on record for this holder in this stock.